| Primary |
| Hypertension |
50.0% |
| Drug Use For Unknown Indication |
33.3% |
| Restlessness |
8.3% |
| Schizophrenia |
8.3% |
|
| Convulsion |
33.3% |
| Joint Swelling |
33.3% |
| Viral Myocarditis |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
23.9% |
| Drug Use For Unknown Indication |
21.1% |
| Psychotic Disorder |
20.6% |
| Depression |
5.0% |
| Sedation |
4.4% |
| Staphylococcal Infection |
3.5% |
| Analgesic Therapy |
3.4% |
| Extrapyramidal Disorder |
2.5% |
| Muscle Spasms |
2.5% |
| Neck Pain |
2.1% |
| Agitation |
1.9% |
| Schizophrenia, Paranoid Type |
1.9% |
| Post-traumatic Stress Disorder |
1.6% |
| Schizophrenia |
1.3% |
| Dyspepsia |
1.2% |
| Cutaneous Lupus Erythematosus |
0.9% |
| Salivary Hypersecretion |
0.7% |
| Constipation |
0.6% |
| Gastric Ph Decreased |
0.4% |
| Neuralgia |
0.4% |
|
| Respiratory Arrest |
25.3% |
| Hypertension |
18.9% |
| Weight Decreased |
10.5% |
| Drug Interaction |
8.4% |
| Cardiac Arrest |
6.3% |
| Intentional Overdose |
4.2% |
| Restlessness |
3.2% |
| Coma Scale Abnormal |
2.1% |
| Convulsion |
2.1% |
| Maternal Exposure During Pregnancy |
2.1% |
| Neurodevelopmental Disorder |
2.1% |
| Normochromic Normocytic Anaemia |
2.1% |
| Sepsis |
2.1% |
| Vision Blurred |
2.1% |
| Vomiting |
2.1% |
| Weight Increased |
2.1% |
| Aphasia |
1.1% |
| Aspiration |
1.1% |
| Asthenia |
1.1% |
| Blood Creatine Phosphokinase Increased |
1.1% |
|
| Concomitant |
| Schizophrenia |
27.7% |
| Product Used For Unknown Indication |
18.6% |
| Drug Use For Unknown Indication |
8.4% |
| Psychotic Disorder |
7.6% |
| Extrapyramidal Disorder |
5.8% |
| Depression |
4.2% |
| Bipolar Disorder |
3.5% |
| Schizoaffective Disorder |
2.7% |
| Hypertension |
2.6% |
| Epilepsy |
2.5% |
| Schizophrenia, Paranoid Type |
2.2% |
| Agitation |
2.0% |
| Affective Disorder |
1.9% |
| Depressed Mood |
1.9% |
| Constipation |
1.5% |
| Insomnia |
1.5% |
| Salivary Hypersecretion |
1.5% |
| Anxiety |
1.4% |
| Diabetes Mellitus |
1.3% |
| Headache |
1.3% |
|
| White Blood Cell Count Increased |
12.9% |
| White Blood Cell Count Decreased |
11.4% |
| Vomiting |
8.6% |
| Sedation |
7.6% |
| Tachycardia |
6.7% |
| Weight Increased |
5.7% |
| Dystonia |
4.3% |
| Psychomotor Hyperactivity |
4.3% |
| Neutropenia |
3.8% |
| Swelling Face |
3.8% |
| Weight Decreased |
3.8% |
| Differential White Blood Cell Count Abnormal |
3.3% |
| Drug Interaction |
3.3% |
| Platelet Count Decreased |
3.3% |
| Oedema Peripheral |
2.9% |
| Perforated Ulcer |
2.9% |
| Pneumonia |
2.9% |
| Prostate Cancer |
2.9% |
| Psychotic Disorder |
2.9% |
| Somnolence |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
18.8% |
| Mental Disorder |
10.4% |
| Neck Pain |
9.1% |
| Analgesic Therapy |
7.8% |
| Depression |
7.8% |
| Sedation |
7.8% |
| Drug Use For Unknown Indication |
7.1% |
| Staphylococcal Infection |
6.5% |
| Back Pain |
3.9% |
| Extrapyramidal Disorder |
3.9% |
| Post-traumatic Stress Disorder |
3.9% |
| Psychotic Disorder |
3.9% |
| Gastric Ph Decreased |
3.2% |
| Muscle Spasms |
2.6% |
| Dyspepsia |
1.9% |
| Oculogyric Crisis |
1.3% |
|
| Hypertension |
40.0% |
| Premature Labour |
12.0% |
| Muscle Rigidity |
8.0% |
| Tremor |
8.0% |
| Viith Nerve Paralysis |
8.0% |
| Asthenia |
4.0% |
| Balance Disorder |
4.0% |
| Drug Interaction |
4.0% |
| Hyperhidrosis |
4.0% |
| Tachycardia |
4.0% |
| Urinary Retention |
4.0% |
|
